<DOC>
	<DOCNO>NCT01826422</DOCNO>
	<brief_summary>The purpose study evaluate effect supplement docosahexaenoic fatty acid eicosapentaenoic fatty acid six month inflammation state well process muscular regeneration metabolic disorder like obesity insulin resistance patient Duchenne muscular dystrophy ( DMD ) Becker muscular dystrophy ( DMB ) compare receive placebo .</brief_summary>
	<brief_title>Effect EPA DHA Inflammation Metabolic Disorders DMD/DMB Patients</brief_title>
	<detailed_description>DMD DMB X-linked disease cause mutation DMD gene , mutation important functional structural consequence skeletal muscle . In muscle fiber observe inflammation necrosis result lose regenerative capacity . The muscle fiber replace connective adipose tissue . In previous study investigator identify 50 % Duchenne Becker patient range thirteen year old obesity . In addition , patient ( N=66 ) hyperinsulinemia ( 53.7 % ) insulin resistance ( 48.5 % ) . It well know obesity , hyperinsulinemia insulin resistance inflammatory background . It demonstrate eicosapentaenoic fatty acid ( EPA ) docosahexaenoic fatty acid ( DHA ) exhibit anti-inflammatory property beneficial effect obesity , hyperinsulinemia insulin resistance child adolescent . Objective : Determine effect EPA DHA inflammation , obesity insulin resistance patient DMD/DMB compare receive placebo .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<criteria>Written inform consent assent patient parent guardian . Patients clinical diagnosis Duchenne Muscular Dystrophy ( DMD ) Becker Muscular Dystrophy ( DMB ) They decide leave study . Consumption dietary supplement contain polyunsaturated fatty acid omega 3 . With hypersensitivity fish oil . Patients respiratory gastrointestinal problem . Medical responsible assessment presence respiratory gastrointestinal problem . Patients difficulty swallow food , include difficulty ingest oil capsule . Gastrostomy feed patient .</criteria>
	<gender>Male</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Muscular Dystrophy</keyword>
	<keyword>Duchenne Muscular Dystrophy</keyword>
	<keyword>Becker Muscular Dystrophy</keyword>
	<keyword>Omega 3</keyword>
	<keyword>Eicosapentaenoic fatty acid</keyword>
	<keyword>Docosahexaenoic fatty acid</keyword>
</DOC>